opioid dependent
PRECEPTOR:
DR. ADHI WIBOWO NURHIDAYAT, SPKJ, MPH
COMPILED BY:
DEBY ARIANDINY
108103000024
DISCA ARIELLA RUCITA 108103000042
FARIDA NUR AINI
108103000053
LELIANA SALEH
108103000008
M. IHSAN SASRANINGRAT
108103000019
Main complaints
Patients come to the Methadone maintenance
program for his own desire to break away
from dependence putau use.
months.
From 2006 to 2009 , the patient only uses putau
experienced visual
hallucinations such as
her to do something.
HOSPITAL CHART
HIV-positive.
Psychosocial Stressors
1.
Parents
: none
2.
Other Family
3.
Friend
: none
4.
Occupation
: none
5.
Financial
: none
6.
Marriage
FAMILY HISTORY
The patient is the first child of four siblings. Third sister female patients.
The first patient's sister had been married and lived with her husband.
Dad worked as a patient while the patient's mother was a housewife.
Currently, patients living with both parents and two sisters. The
patient was very close to his mother than with other family members.
Genogram
S, 53
J, 31
A, 57
E, 28
T, 51
J, 48
R, 45
M,
25
T, 21
A, 12
T, 42
W, 39
PHYSICAL CONDITION
General condition: Good
impression
Skin: tan
removed
Eyes: not pale conjunctiva, sclera
jaundice is not
Ear nose and throat : No wax; was no
PHYSICAL CONDITION
Neck: no lymphadenopathy
Heart: I-II heart sounds normal, no murmurs and gallops
Lungs: symmetrical right and left as static and dynamic, vesicular,
Diagnosis Psychiatric
General Description
Mood : eutim
Afek : mismatched
looked calm
Discussion : spontaneous , no
language disorders
Intellectual function
Level of education :
immediate : good
intellectual functioning in
Short-term : good
Long-term good
Memory :
Concentration : good
Orientation :
place : good
time : good
good
people : good
Impaired perception : no
Diagnosis Psychiatric
Mind
power value
degree of VI
Reliable level : as a whole
can be trusted .
6 September 2011
Benzodiazepines: negative
Cannabis: negative
Opiate: negative
Resume
Formula Diagnosis
Aksis I
the patient had no history of
head injury due to an accident.
On physical examination
found no common medical
conditions that affect brain
function.
the patient's routine use of inhaled putau
since 2002 and injected since 2006.
Initially, patients using 200 thousand putau
use 2-3 times per day and last use as much as
half a gram putau, 2-3 times per day.
If the patient discontinue the use of putau
will feel withdrawal symptoms so that the
patient continues to use putau.
organic mental
disorders can be
ruled out.
dependence of
the opioid
Formula Diagnosiss
Aksis II
Alloanamnesis:
Personality
disorder threshold
Formula Diagnosiss
Aksis III
Friends in the working environment of patients who died of drug use
with HIV positive and often exchanging syringes.
Patients said doctors RSKO declared HIV positive patients with CD4
results 234 sl / ul.
From the results of a physical examination found a blackish colored
crusting
Aksis IV
patients having marital problems, namely the desire to have
a life partner but has a positive HIV disease.
Formula Diagnosiss
Aksis V
Based on the Global Assessment of Functioning scale
(GAF)
Evaluation Multiaxial
Axis I
Axis III
Axis IV
: marriage problems
Axis V
Problem List
Organobiologis: HIV-positive
Psychology: not married
Environmental and socio-economic: no
Prognosis
Quo ad vitam: dubia ad malam
The patient was diagnosed HIV positive in 2011 and only ARV
treatment for 1 year and did not continue the treatment
Quo ad functionam: dubia ad malam
Patients diagnosed HIV-positive and had a history of oral and
papules kruritik candidiasi eruption. This suggests HIV patients
had grade III
Quo ad sanationam: dubia ad bonam
Patients already undergoing methadone maintenance treatment for
approximately 3 years and do not mix it with the use of any substance. In
theory, the use of methadone as a substitution therapy in opioid dependence
is shown to have many uses one of which
Management
Initial dose: 1 x 25 mg Metadone
The current dose: 1 x 185 mg Metadone
Methadone is an opioid substitution
therapy that are agonists. the initial
phase, a given dose of methadone is 2040 mg per day.
In order to reach the threshold value of
methadone in the blood, plus or minus the
initial dose of 5-10 mg for 3-24 hours.
To achieve longer considered adequate dose
increase or decrease the dosage until the
detoxification
opioida
continued
with
methadone maintenance therapy.
Prompts examination
Follow-up CD4 every 6 months.
Opiate dependence
Define
Opioid dependence is a cluster of physiological, behavioral,
Opioid
Morphine
Codeine
Heroin (diacetylmorphine)
Hydrocodone
Hydromorphone
(dihydromorphinone)
Oxymorphone
(dihydrohydroxymorphinone)
Levorphanol
Methadone
Meperidine (pethidine)
Pethadol Fentanyl
(dihydrocodeinone)
Drocode (dihydrocodeine)
Oxycodone
(dihydrohydroxycodeinone)
Propoxyphene
Buprenorphine
Pentazocine
Neuropharmocology
Heroin
35
Heroin is an illegal drug with the
following features:
poppy.
It is a "downer" or depressant
Heroin
Black Tar
Heroin
Powder Heroin
36
37
Short-term Effects
Appears soon after a single dose and disappears in a few hours
After injection, a surge of euphoria ("rush") accompanied by a
Long-term Effects
Collapsed veins, infection of heart lining and valves,
pneumonia
Additives that do not dissolve result in clogging the blood
39
Mangement
Observation of vital sign
Anamnesis about drug use
Overdoses of opioid Naloxone is administered IV
Opioid substitute
Opioid detoxification methadone (A daily dosage of 20 to 80 mg, up to
120 mg )
Levomethadyl (LAAM) It is no longer used
Buprenorphine (a daily dose of 8 to 10 mg)
Clonidine
Pentazocine
Complication:
HIV /AIDS
Hepatitis
Death
Pathogenesis
Classified as having HIV retrovirus RNA genetic
Immuno
Sorbent
with
enzymes
Assay
(ELISA),
Western
blot,
Major symptoms:
Body weight decreased by more
Generalized dermatitis.
than 1 month.
month.
of
herpes
Loss
consciousness
and
neurological disorders.
Dementia / HIV encephalopathy.
zoster
recurrent
multisegmental.
Kandidias oropharyngeal.
Herpes simplex chronic progressive.
Generalized lymphadenopathy.
Cytomegalovirus retinitis
HIV Treatment
Anti Retroviral Reverse Transcriptase Nucleoside
Inhibitors Enzyme .
1 . AZT ( Azidothimidine ) / Zidovudin
2.Didanosine (ddI)
3.Stavudine ( d4T )
4.Lamivudine
Bibliography